缓解托法西提尼布诱导的不良事件的风险,在老年人群与性结肠炎
Anna Viola1, Raffaele Li Voti1,2, Chiara Bivacqua1,2
1Deparrtment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Journal of Crohn's & colitis
|September 13, 2023
概括
在老年性结肠炎患者中使用托法西提尼布需要仔细监测不良事件. 剂量调整和抗血栓治疗可以减轻心血管和血栓栓塞的风险,而疹疫苗是有效的.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 接受托法西提尼布治疗的性结肠炎 (UC) 的老年人面临心血管事件,血栓栓塞,疹和恶性瘤的风险.
- 由于安全问题,监管机构已将facitinib的使用限制在该人群中.
研究的目的:
- 为了评估老年UC患者治疗tofacitinib的不良事件的发生情况.
- 确定这些不良事件的潜在预防措施.
主要方法:
- 用托法西提尼布治疗的患者的回顾性评估,根据并发症和年龄分为两组 (查尔森并发症指数≥2vs≤1).
- 记录患者和疾病相关的变量,包括治疗反应,剂量修改和同时进行的抗血栓治疗.
主要成果:
- 两组之间没有观察到主要或次要治疗失败的显著差异.
- 在12个月后,可比的无类固醇缓解率为53%和46%
- 在复合性疹疫苗接种后,疹发病率下降;没有记录重大心血管事件或血栓塞栓症. 在伴随性疾病较高的组中,有两名患者患有恶性瘤.
结论:
- 调节诱导剂量和使用抗血栓治疗可以预防心脏病事件和血栓塞栓症.
- 疫苗接种有效地消除了疫苗接种后出现疹病毒的风险.
- 在开始对老年患者服用托法西提尼布之前,对患者进行彻底的检查至关重要,以确定潜在的恶性瘤.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
168
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
168
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
190
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
190
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
544
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
544
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
463
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
463
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
395
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
395


